Back

Integration of transcriptional signatures from brain tissue and plasma extracellular vesicles of a preclinical tauopathy mouse model

Lucy, T. T.; Mamun-Or-Rashid, A. N. M.; Lee, D. C.; Lefterov, I.; Koldamova, R.; Fitz, N. F.

2026-05-11 neuroscience
10.64898/2026.05.06.723062 bioRxiv
Show abstract

Tauopathies, including Alzheimers disease, involve progressive neurodegeneration and sustained neuroinflammation. We present a multi-compartment transcriptomic atlas of 9.6-month-old PS19 tauopathy mice compared with wild-type (WT) controls (n=8/group), profiling cortical mRNA, cortical non-coding RNA (ncRNA), and plasma small extracellular vesicle (pEV) ncRNA. In the PS19 cortex, mRNA sequencing identified 917 differentially expressed genes (DEGs), with microglial deconvolution revealing a robust transition toward disease-associated microglia (DAM) gene signature and downregulation of genes involved in oxidative phosphorylation and cholesterol biosynthesis relative to WT. Cortical ncRNA profiling identified 466 differentially expressed ncRNAs, primarily circular RNAs (circRNAs; n=331). In pEVs, 822 ncRNAs were differentially abundant, of which 657 circRNAs were identified in PS19 compared to WT mice. Cross-compartment integration demonstrated that pEV miRNA gene targets functionally mirrored genes involved in the brains inflammatory and metabolic failure. We identified a core shared signature of 33 ncRNAs, including miR-5114 (up in brain, down in pEV), circ_0008242 and circ_0002153 (up in brain and pEV), and circ_0007688 (down in brain and pEV) differentially enriched across both brain and periphery in PS19 compared to WT mice. These results demonstrate that the pEV non-coding landscape effectively tracks central tau-mediated changes in the brain transcriptional response. This study identifies circRNAs as the most numerically perturbed ncRNA class and provides a foundation for non-invasive biomarker development in tauopathy.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Alzheimer's & Dementia
143 papers in training set
Top 0.6%
12.1%
2
Molecular Neurodegeneration
49 papers in training set
Top 0.1%
9.9%
3
Nature Communications
4913 papers in training set
Top 27%
6.7%
4
Cell Reports
1338 papers in training set
Top 8%
6.2%
5
Neuron
282 papers in training set
Top 3%
4.8%
6
Brain
154 papers in training set
Top 1%
4.8%
7
Acta Neuropathologica
51 papers in training set
Top 0.2%
4.2%
8
Acta Neuropathologica Communications
81 papers in training set
Top 0.2%
3.9%
50% of probability mass above
9
Neurobiology of Disease
134 papers in training set
Top 2%
3.5%
10
Nature Neuroscience
216 papers in training set
Top 3%
3.0%
11
Cell Reports Medicine
140 papers in training set
Top 4%
1.7%
12
Molecular Psychiatry
242 papers in training set
Top 2%
1.7%
13
Genome Medicine
154 papers in training set
Top 5%
1.7%
14
Scientific Reports
3102 papers in training set
Top 62%
1.5%
15
Science Advances
1098 papers in training set
Top 22%
1.3%
16
Science Translational Medicine
111 papers in training set
Top 4%
1.3%
17
Advanced Science
249 papers in training set
Top 15%
1.2%
18
eneuro
389 papers in training set
Top 7%
1.2%
19
Journal of Neuroinflammation
50 papers in training set
Top 0.7%
1.1%
20
Molecular Therapy
71 papers in training set
Top 2%
0.9%
21
Annals of Neurology
57 papers in training set
Top 2%
0.9%
22
Aging Cell
144 papers in training set
Top 3%
0.9%
23
iScience
1063 papers in training set
Top 27%
0.9%
24
The Journal of Neuroscience
928 papers in training set
Top 8%
0.8%
25
PLOS ONE
4510 papers in training set
Top 66%
0.8%
26
Communications Biology
886 papers in training set
Top 22%
0.8%
27
Biological Psychiatry
119 papers in training set
Top 3%
0.7%
28
Journal of Experimental Medicine
106 papers in training set
Top 4%
0.7%
29
Life Science Alliance
263 papers in training set
Top 2%
0.7%
30
Alzheimer's Research & Therapy
52 papers in training set
Top 2%
0.7%